Medtronic 780G System

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This study will evaluate the safety and effectiveness of the MiniMed 780G insulin pump system used in combination with the DS5 CGM in type 1 diabetic pediatric participants in a home setting.

Eligibility & Criteria

IRB #:
23-020801
Official Title:
Medtronic MiniMed, Inc. (“Medtronic”) / “Safety and Effectiveness Evaluation of the MiniMed™ 780G System Used in Combination with the DS5 CGM”
Study Phase:
Phase III
Eligible Age Range:
7 - 17 Years
Gender:
All
Study Categories:

Visit Criteria

Over a 3.5-month period, you will learn to use the Medtronic 780G automated insulin delivery system. An office visit at CHOP Philadelphia is required to consent to participate and to start the study devices. There are a total of five other office visits and 8 phone visits. Virtual office visits may be performed for cases where an in-person visit is not possible. None of the procedures in this study are experimental. Participants will be compensated.

LEADER

Brynn Marks